289 related articles for article (PubMed ID: 28571564)
1. Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new.
Frezza AM; Stacchiotti S; Gronchi A
BMC Med; 2017 Jun; 15(1):109. PubMed ID: 28571564
[TBL] [Abstract][Full Text] [Related]
2. Advances of systemic treatment for adult soft-tissue sarcoma.
Liu W; Jiang Q; Zhou Y
Chin Clin Oncol; 2018 Aug; 7(4):42. PubMed ID: 30173532
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapies for adult soft tissue sarcoma.
Radaelli S; Stacchiotti S; Casali PG; Gronchi A
Expert Rev Anticancer Ther; 2014 Jun; 14(6):689-704. PubMed ID: 24555529
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in soft-tissue sarcoma.
Ayodele O; Razak ARA
Curr Oncol; 2020 Feb; 27(Suppl 1):17-23. PubMed ID: 32174754
[TBL] [Abstract][Full Text] [Related]
5. Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.
Skafida E; Kokkali S; Nikolaou M; Digklia A
Expert Rev Anticancer Ther; 2017 Jun; 17(6):537-543. PubMed ID: 28425820
[TBL] [Abstract][Full Text] [Related]
6. Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtype.
Martín-Broto J; Reichardt P; Jones RL; Stacchiotti S
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):15-28. PubMed ID: 32349558
[No Abstract] [Full Text] [Related]
7. Next frontiers in systemic therapy for soft tissue sarcoma.
Yen CC; Chen TW
Chin Clin Oncol; 2018 Aug; 7(4):43. PubMed ID: 30173533
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
Canter RJ; Qin LX; Downey RJ; Brennan MF; Singer S; Maki RG
Cancer; 2007 Nov; 110(9):2050-60. PubMed ID: 17828771
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler M; Gosheger G; Jobke B; Reichardt P; Tunn PU
Br J Cancer; 2015 Feb; 112(3):455-60. PubMed ID: 25535732
[TBL] [Abstract][Full Text] [Related]
10. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
[TBL] [Abstract][Full Text] [Related]
11. Advances and controversies in the management of soft tissue sarcomas.
Demetri GD; Blay JY; Casali PG
Future Oncol; 2017 Jan; 13(1s):3-11. PubMed ID: 27918199
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience.
Rastrelli M; Campana LG; Valpione S; Tropea S; Zanon A; Rossi CR
Int J Hyperthermia; 2016; 32(2):165-72. PubMed ID: 26608883
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).
Garcia del Muro X; de Alava E; Artigas V; Bague S; Braña A; Cubedo R; Cruz J; Mulet-Margalef N; Narvaez JA; Martinez Tirado O; Valverde C; Verges R; Viñals J; Martin-Broto J;
Cancer Chemother Pharmacol; 2016 Jan; 77(1):133-46. PubMed ID: 26563256
[TBL] [Abstract][Full Text] [Related]
14. Update on systemic therapy for advanced soft-tissue sarcoma.
Smrke A; Wang Y; Simmons C
Curr Oncol; 2020 Feb; 27(Suppl 1):25-33. PubMed ID: 32174755
[TBL] [Abstract][Full Text] [Related]
15. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS).
Ray-Coquard I; Collard O; Ducimetiere F; Laramas M; Mercier F; Ladarre N; Manson S; Tehard B; Clippe S; Suchaud JP; Stefani L; Blay JY
BMC Cancer; 2017 Feb; 17(1):111. PubMed ID: 28173774
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
18. Newer therapeutic strategies for soft-tissue sarcomas.
Bourcier K; Italiano A
Pharmacol Ther; 2018 Aug; 188():118-123. PubMed ID: 29481809
[TBL] [Abstract][Full Text] [Related]
19. New therapies in soft tissue sarcoma.
Vincenzi B; Frezza AM; Santini D; Tonini G
Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
[TBL] [Abstract][Full Text] [Related]
20. Issues in the management of high-risk localized sarcomas.
Cardona K; Movva S
Curr Probl Cancer; 2013; 37(2):62-73. PubMed ID: 23719331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
